COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
Vittorio Mantero, Lucia Abate, Paola Basilico, Roberto Balgera, Andrea Salmaggi, Bardia Nourbakhsh, Christian Cordano
Topics & Concepts
TeriflunomideMultiple sclerosisMedicineDimethyl fumarateNeurologyCoronavirus disease 2019 (COVID-19)FingolimodAlemtuzumabPopulationInternal medicineNeuroradiologyDiseasePediatricsImmunologyPsychiatryTransplantationEnvironmental healthInfectious disease (medical specialty)Multiple Sclerosis Research StudiesAutoimmune and Inflammatory Disorders ResearchPeripheral Neuropathies and Disorders